Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens

Journal of Medical Microbiology

Volumn 44, Issue 1, 1996, Pages 44-51

  Trautmann, M ^a   Cross, A S ^b   Reich, G ^c   Held, H ^b,c   Podschun, R ^d   Marre, R ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL INFECTION; KLEBSIELLA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEPTICEMIA; SPECIES DIFFERENTIATION; STRAIN DIFFERENCE;

EID: 0030043888     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-1-44     Document Type: Article

References (39)

1. Horan T, Culver D, Jarvis W et al. Pathogens causing nosocomial infections. Preliminary data from the National Nosocomial Infections Surveillance System. Antimicrob Newsletter 1988; 5: 65-67.
2. Bodey GP, Elting LS, Rodriguez S, Hernandez M. Klebsiella bacteremia. A 10-year review in a cancer institution. Cancer 1989; 64: 2368-2376.
3. Feldman C, Smith C, Levy H, Ginsburg P, Miller SD, Koornhof HJ. Klebsiella pneumoniae bacteraemia at an urban general hospital. J Infect 1990; 20: 21-31.
4. Gouby A, Neuwirth C, Bourg G et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994; 32: 301-305.
5. Geerdes HF, Ziegler D, Lode H et al. Septicemia in 980 patients at a University hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 1992; 15: 991-1002.
6. Cryz SJ, Pitt TL, Fürer E, Germanier R. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 1984; 44: 508-513.
7. Pennington JE, Pier GB, Sadoff JC, Small GJ. Active and passive immunization strategies against Pseudomonas aeruginosa pneumonia. Rev Infect Dis 1986; 8 Suppl 4: S426-S433.
8. Cryz SJ, Fürer E, Cross AS, Wegmann A, Germanier R, Sadoff JC. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. J Clin Invest 1987; 80: 51-56.
9. Cross A, Artenstein A, Que J et al. Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers. J Infect Dis 1994; 170: 834-840.
10. Casewell M, Talsania HG. Predominance of certain Klebsiella capsular types in hospitals in the United Kingdom. J Infect 1979; 1: 77-79.
11. Ullmann U. The distribution of Klebsiella pneumoniae serotypes from different sources and their sensitivity to cephalosporins. Infection 1983; 11 Suppl 1: S28-S31.
12. Podschun R, Heineken P, Ullmann U, Sonntag HG. Comparative investigations of Klebsiella species of clinical origin: plasmid patterns, biochemical reactions, antibiotic resistance and serotypes. Zentralbl Bakteriol Mikrobiol Hyg A 1986; 262: 335-345.
13. Simoons-Smit AM, Verweij-Van Vught AMJJ, MacLaren DM. The role of K antigens as virulence factors in Klebsiella. J Med Microbiol 1986; 21: 133-137.
14. Held TK, Trautmann M, Mielke MEA, Neudeck H, Cryz SJ, Cross AS. Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia. Infect Immun 1992; 60: 1771-1778.
15. McCallum KL, Schoenhals G, Laakso D, Clarke B, Whitfield C. A high-molecular-weight fraction of smooth lipopolysaccharide in Klebsiella serotypc O1:K20 contains a unique O-antigen epitope and determines resistance to nonspecific serum killing. Infect Immun 1989; 57: 3816-3822.
16. Tomás JM, Benedi VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986; 54: 85-89.
17. Straus DC, Atkisson DL, Garner CW. Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae. Infect Immun 1985; 50: 787-795.
18. Ørskov I. O antigens in the Klebsiella group. Acta Pathol Microbiol Scand 1954; 34: 145-156.
19. Fujita S, Matsubara F. Latex agglutination test for O serotyping of Kiebsiella species. Microbiol Immunol 1984; 28: 731-734.
20. Mizuta K, Ohta M, Mori M, Hasegawa T, Nakashima I, Kato N. Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect Immun 1983; 40: 56-61.
21. Alberti S, Hernández-Allés S, Gil J et al. Development of an enzyme-linked immunosorbent assay method for typing and quantitation of Klebsiella pneumoniae lipopolysaccharide: application to serotype O1. J Clin Microbiol 1993; 31: 1379-1381.
22. Ørskov I, Fife-Asbury MA. New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned. Int J Syst Bacteriol 1977; 27: 386-387.
23. Kaluzewski S. Somatic antigens of Klebsiella strains K63-K72. Med Dosw Mikrobiol 1965; 17: 283-290 (in Polish).
24. Nimmich W, Korten G. Die chemische Zusammensetzung der Klebsiella-Lipopolysaccharide (O-Antigene). Pathologia et Microbiologia 1970; 36: 179-190.
25. Kenne L, Lindberg B. Bacterial polysaccharides. In: Aspinall GO (ed) The polysaccharides, vol 2. Orlando, Academic Press, 1983: 287-363.
26. Kelly RF, Severn WB, Richards JC et al. Structural variation in the O-specific polysaccharides of Klebsiella pneumoniae serotype O1 and O8 lipopolysaccharide: evidence for clonal diversity in rfb genes. Mol Microbiol 1993; 10: 615-625.
27. Ørskov I, Ørskov F. Serotyping of Klebsiella. Methods Microbiol 1984; 14: 143-164.
28. Whitfield C, Richards JC, Perry MB, Clarke BR, MacLean LL. Expression of two structurally distinct D-galactan O antigens in the lipopolysaccharide of Klebsiella pneumoniae serotype O1. J Bacteriol 1991; 173: 1420-1431.
29. Trautmann M, Vogt K, Hammack C, Cross AS. A murine monoclonal antibody defines a unique epitope shared by Klebsiella lipopolysaccharides. Infect Immun 1994; 62: 1282-1288.
30. Kauffmann F. On the serology of the Klebsiella group. Acta Pathol Microbiol Scand 1949; 26: 381-406.
31. Cross AS, Gemski P, Sadoff JC, Ørskov F, Ørskov I. The importance of the K1 capsule in invasive infections caused by Escherichia coli. J Infect Dis 1984; 149: 184-193.
32. Podschun R. Phenotypic properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources. Zentralbl Hyg 1990; 189: 527-535.
33. Podschun R, Ullmann U. Isolation of Klebsiella terrigena from clinical specimens. Eur J Clin Microbiol Infect Dis 1992; 11: 349-352.
34. Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965; 5: 83-91.
35. Cryz SJ, Fürer E, Germanier R. Purification and vaccine potential of Klebsiella capsular polysaccharides. Infect Immun 1985; 50: 225-230.
36. Blumenkrantz N, Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem 1973; 54: 484-489.
37. Gransden WR, Eykyn SJ, Phillips I, Rowe B. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis 1990; 12: 1008-1018.
38. Kasama H. Serological classification of Pseudomonas aeruginosa by a slide agglutination test. J Clin Microbiol 1978; 8: 181-188.
39. Whitfield C, Perry MB, MacLean LL, Yu SH. Structural analysis of the O-antigen side chain polysaccharides in the lipopolysaccharides of Klebsiella serotypes O2(2a), O2(2a, 2b), and O2(2a, 2c). J Bacteriol 1992; 174: 4913-4919.